首页 | 本学科首页   官方微博 | 高级检索  
     

血竭联合柳氮磺吡啶治疗非特异性溃疡性结肠炎疗效观察
引用本文:李敏,刘兰英. 血竭联合柳氮磺吡啶治疗非特异性溃疡性结肠炎疗效观察[J]. 中成药, 2004, 26(3): 213-214
作者姓名:李敏  刘兰英
作者单位:川北医学院附院肛肠科,四川,南充,637000
摘    要:目的:观察血竭联合柳氮磺吡啶治疗非特异性溃疡性结肠炎(UC)的疗效.方法:将40例UC患者分为治疗组(20例)和对照组(20例),两组除采用柳氮磺吡啶口服及保留灌肠外,治疗组加用血竭口服及保留灌肠.结果:治疗组的近期治愈率、总有效率、半年复发率分别为60%,95%,15.8%.对照组分别为20%,65%,61.5%,两组有显著性差异(P<0.05).结论:血竭联合柳氮磺吡啶可显著促进UC缓解,减少复发.

关 键 词:血竭  溃疡性结肠炎  柳氮磺吡啶
文章编号:1001-1528(2004)03-0213-02

Observation of curative effect of Sanguis Draxonis combined with SASP in the treatment of non-specific ulcerative colitis
LI Min,LIU Lan-yin. Observation of curative effect of Sanguis Draxonis combined with SASP in the treatment of non-specific ulcerative colitis[J]. Chinese Traditional Patent Medicine, 2004, 26(3): 213-214
Authors:LI Min  LIU Lan-yin
Abstract:AIM: To observe the curative effect of Sanguis Draconis combined with salicylazosulfapyridine(SASP) in the treatment of non-specific ulcerative colitis(UC). METHODS : 40 cases with UC were divided into the treatment group(20 cases) and the control group(20 cases). Both groups were given SASP per-orally and retention-enema to treat the disease. In addition,the treatment group was also given Sanguis Draxconis per-orally and retention-enema. RESULTS : The short-term curative rate,the total effective rate and the recurrence rate were 60%,95% and 15.8% respectively in the treatment group,and 20%,65% and 61.5% respectively in the control group;there was a great difference between the two groups( P <0.05). CONCLUSION : The integrative therapy can greatly promote the relief and reduce the recurrence of UC.
Keywords:Sanguis Draxconis  ulcerative colitis  SASP
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号